3 Biotech Stocks With Revenue Up To 11%
AI related risks just jumped to the top of the Federal Reserve’s financial stability worries, with a surge in complex debt tied to AI infrastructure. That kind of boom and scrutiny can push investors to look at other cutting edge areas. Carefully chosen biotech stocks with solid balance sheets can offer a different source of potential high upside. This article walks through three such biotech opportunities from our US screener. The three biotech stocks covered below are only a small sample...
AI related risks just jumped to the top of the Federal Reserve’s financial stability worries, with a surge in complex debt tied to AI infrastructure. That kind of boom and scrutiny can push investors to look at other cutting edge areas. Carefully chosen biotech stocks with solid balance sheets can offer a different source of potential high upside. This article walks through three such biotech opportunities from our US screener. The three biotech stocks covered below are only a small sample...
What's Your Reaction?
